Atlas Trials

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Clinical trial NCT00305812 · COMPLETED

Trial details

NCT number
NCT00305812
Sponsor
NCIC Clinical Trials Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
2006-03-09
Primary completion
2008-06-30
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.